Top Markets
Coin of the day
Apimeds Pharmaceuticals US, Inc Apimeds Pharmaceuticals US, Inc

Apimeds Pharmaceuticals US, Inc

APUS
Pozycja w akcjach #33687
Apimeds Pharmaceuticals US, Inc. (APUS) functions as a clinical-stage... Apimeds Pharmaceuticals US, Inc. (APUS) functions as a clinical-stage biopharmaceutical firm operating within the United States. This company is dedicated to the entire lifecycle of its flagship product, Apitox – from its initial investigation and development to its production, market introduction, and sales. Apitox, a key active pharmaceutical ingredient, is specifically designed to alleviate inflammation and manage pain symptoms experienced by individuals suffering from osteoarthritis and multiple sclerosis. Established in 2020, APUS has its corporate headquarters situated in Hopewell, New Jersey, and operates as a subsidiary of Api Meds, Inc.
Cena akcji
$4.70
Ostatnia synchronizacja: 2026-08-14
Kapitalizacja rynkowa
$7.09M
Zmiana (1 dzień)
-0.21%
Zmiana (1 rok)
-70.63%
Kraj
US
Handel Apimeds Pharmaceuticals US, Inc (APUS)

Kategoria

Historia stopy dywidendy dla Apimeds Pharmaceuticals US, Inc (APUS)
Stopa dywidendy (TTM) dla Apimeds Pharmaceuticals US, Inc (symbol akcji: APUS) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Apimeds Pharmaceuticals US, Inc (APUS) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji